Predicting cancer based on average telomere length is problematic
When we discuss the risk of telomere length to cancer risk, there are many studies but the conclusions we reach are limited by our simplistic assumptions.
When we discuss the risk of telomere length to cancer risk, there are many studies but the conclusions we reach are limited by our simplistic assumptions.
In this 62-minute, we have a cheerful and accessible discussion that nonetheless goes quite deeply into my Telomere/Stem Cell Theory of Aging- right down a breakdown of Koch’s Postulates (the foundation of establishing disease causation versus correlation), the nature of stem cells, and how to naturally live longer and healthier
When a person realizes that we are all time travelers without “do-overs” moving at a speed of one day per day through our lives, we can accept responsibility for untoward events, whether they be of equal, lesser, or higher probability because of our actions.
I sat down with noted telomere scientist, Dr. Bill Andrews, the CEO of Sierra Sciences. He explains how the misconception of telomerase causing cancer got started and why it actually is the opposite.
Craig Sagar used the assumption that a ridiculous outfit would put the interviewee at ease. I’d say he got a lot done ‘playing the fool’ while keeping a keen focus on content.
Fidel Castro was 90 years old and like most dictators, institutions, and ideologies, he never lost sight of the “Divine right of kings”
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness